The objective of this study was to select appropriate bacteriophages that survive in the gastrointestinal tract of neonatal poultry and utilize those bacteriophages to reduce intestinal colonization of Salmonella enteritidis phage type 13A (SE) in challenged birds. Broiler chicks served as an in vivo biological filter to preferentially select bacteriophages from our bacteriophage library capable of surviving the gastrointestinal environment. A mixture of bacteriophage isolates designated PHL 1-71 was administered orally to three SE challenged chicks on three consecutive days. Each day, bacteriophages were recovered from the ileum, ileocecal junction and ceca for sequential administration the following day. The recovered bacteriophages were then administered to SE-infected turkey poults. In the first experiment, two-day old poults were challenged with 10 cfu SE and treated 48 h later with 5mM Mg (OH) followed by 2.5×10 plaque 4 9 2 forming units (pfu) of bacteriophages in 1mM Mg (OH) solution. This treatment numerically reduced SE 2 recovered from cecal contents at 12 and 24 h after treatment as compared to untreated controls. In a second experiment, two-day old poults were challenged with 1.6×10 cfu SE and treated with 5mM Mg (OH) followed of cecal contents in the control group and 11,224 cfu/g in the phage treated group 24 h post treatment. These data were not significantly different, but they suggest that bacteriophages can be preferentially selected in vivo to increase survival in the avian gastrointestinal tract. However, improved efficacy is required prior to useful application of the approach for reducing Salmonella infection.
Introduction
In the United States, it is estimated that 1.4 million humans contract salmonellosis and that the annual cost of this illness, including lost productivity, is $3 billion annually (WHO, 2006) . In the year 2004, surveillance data indicated that the greatest number of foodborne illnesses was caused by Salmonella, comprising 42% of all laboratory diagnoses (FoodNet, 2005) . Because many of these illnesses are associated with poultry and poultry products (Bean and Griffin, 1990; Persson and Jendteg, 1992) , the reduction of microbial contamination during the production of poultry is important. Currently we are exploring the use of bacteriophages as a method to control Salmonella enteritidis (SE) infections i n poultry. We previously isolated bacteriophages that lyse SE (Higgins et al., 2005) and here selected those that are most adapted to the gastrointestinal tract t o potentially treat SE infected birds. Poultry harboring Salmonella infections can be treated with antibiotics with some success (Goodnough and Johnson, 1991; Muirhead, 1994) . However, Manning et al. (1992 Manning et al. ( , 1994 reported increased Salmonella colonization when chickens are treated with selected antibiotics, possibly due to reduction of normal bacterial flora in the gastrointestinal tract that serve as a natural barrier to Salmonella infection. Additionally, Kobland et al. (1987) and Gast et al. (1988) have recovered antibiotic resistant Salmonella from experimentally challenged birds treated with antibiotics. Recently, the United States Food and Drug Administration (FDA) has banned the use of enrofloxacin in poultry production because of the increase in resistant Campylobacter infections in humans (FDA, 2005) . Thus, it is important that effective and inexpensive methods or products to treat bacterial infections in sick birds be developed. One possible alternative to antibiotic treatment, is use of bacteriophages to eliminate or control bacterial infections. Bacteriophages are viruses that infect and replicate in prokaryotic cells rather than eukaryotic cells (Cann, 1993; Voyles, 1993) . They are ubiquitous in the environment and readily isolated from water sources, sewage and soil. Bacteriophages are also host specific and usually can infect only one serotype within a bacterial species (Ackermann et al., 1978) . Huggins (1983, 1987) have successfully used bacteriophages to eliminate Escherichia coli (E. coli) infections in calve, pigs and lambs. Bacteriophages have also been used with some success at eliminating poultry pathogens. Barrow et al. (1998) This experiment also clearly demonstrated that the bacteriophage increased i n Bacteriophage preparation: All bacteriophages were numbers as long as the host was present. Recently, maintained on TSA soft agar plates as described above. Huff et al. (2002 Huff et al. ( , 2003 Huff et al. ( and 2005 accomplished by mixing the cell free bacteriophage bacteriophages that were better adapted to survive the suspension, a turbid SE culture (12h at 37 C) and fresh gastrointestinal environment. As a selection tool, w e TSB combined at a ratio of 1:3:5 respectively and then used broiler chicks as a biological filter to select incubated at 37°C for 1.5 h. This amplification procedure bacteriophages capable of surviving passage through was repeated three times in vitro. The final titer of the the gastrointestinal tract. The selected bacteriophages bacteriophage mixture was approximately 10 pfu/mL were then evaluated in vivo in SE-challenged turkey as determined by soft overlay plating. poults to determine their effectiveness.
Materials and Methods
Bacteriophage isolation: Wastewater samples were obtained from a local municipal wastewater treatment plant and filtered through a 0.2 µm syringe filter . A 2 combination of 100 µL of 10 cfu/mL SE and 1 mL of the 7 wastewater sample filtrate was added to 1.5 mL o f Tryptic Soy Agar (TSA) and poured over a warm TSA 3 petri plate. Plates were incubated overnight at 37 C and those with confluent lysis of SE were flooded with 15 mL of sterile 0.9% NaCl (saline). The fluid was then poured off the plate and filtered through a 0.2 µm filter . Serial 1 ten-fold dilutions were made in saline. Thin agar overlay plates were poured as described above containing 1 mL of e ach bacteriophage dilution. Individual plaques resulting from this plating were differentiated on the basis of plaque morphology and selected by removing an agar plug. Each distinct plaque morphology was then sequentially passed on TSA plates three times to purify the isolate. This technique yielded 71 bacteriophage isolates from four independent wastewater samples. Bacteriophage isolates were arbitrarily designated PHL 1-PHL 71 for identification purposes. While several different plaque morphologies were noted and isolates were obtained from four different wastewater samples, no attempts to In vivo biological filter: Ten, day-of-hatch Cobb 500 broiler chicks were orally challenged with 10 cfu of SE 4 in a 0.25-mL volume of TSB. Chicks used in all experiments were cared for using procedures approved by the University of Arkansas Institutional Animal Care and Use Committee. The chicks were maintained on clean pine shavings in a floor pen at age-appropriate temperature with feed and water ad libitum. Immediately prior to bacteriophage administration (0.25 m L containing ~2.5×10 pfu), a feed passage marker, ferric 9 oxide (100 mg) was administered per os. When red 6 feces were detected from an individual chick (1-3 h), that chick was humanely killed by CO inhalation and 2 samples from the gastrointestinal tract were obtained. The lower 4 cm of the ileum and ileocecal junction and half of both cecal pouches were removed aseptically from each chick. The combined tissues from each bird were minced with scissors and placed in a sterile tube containing 10 mL of TSB and incubated at 37 C for 1 h. o Samples were stored on wet ice until samples were obtained from all three chicks and each sample had been incubated for 1 h. Following recovery of surviving bacteriophages, these bacteriophages were re-amplified in vitro prior to repassage through chicks. The samples were centrifuged for 10 min at 3000 rpm (1864×g) and a total of 20 mL of supernatant was pooled from all tubes and sterile forming units of SE per gram of cecal contents was filtered through a 0.2 µm syringe filter. Pooled filtrate was incubated with 10 mL of fresh TSB in the presence of 3×10 cfu of SE at 37 C for 15 h. Following incubation, 20 3 o mL was filtered and passed with 20 mL of fresh TSB and 0.4 mL of 10 cfu of SE and incubated for 5 h. The 7 bacteriophages underwent two additional amplifications utilizing the 1:3:5 ratio for bacteriophage, SE and TSB respectively and incubation for 2 h at 37 C. The final o bacteriophage titer after the first passage through chicks and subsequent amplification was 10 pfu/mL. This 10 procedure for passaging bacteriophages through chicks was repeated two additional times. Bacteriophage present in the tissue samples of the third in vivo passage were amplified by standard methods to generate a stock. These bacteriophages represent a Group 3 received the same initial treatment as group 2, heterogenous subpopulation from the original wild-type pool that are tolerant of low pH and other enteric conditions as evidenced by survival in three consecutive passages through the proventriculus of chicks. Ten soft agar plates with undiluted bacteriophage were created to retain samples of these bacteriophages.
In vivo evaluation:
In Experiment 1, One hundred twenty turkey poults were obtained on day-of-hatch and randomly divided into three groups of 40. Poults were placed in brooder rings on clean pine shavings, provided feed and water ad libitum and maintained at an age-appropriate temperature for the duration of the experiment as above. The control group was maintained in a BSL-3 capable isolation room separate from the two groups of poults receiving bacteriophage treatment. All poults received a challenge of 10 cfu of SE by oral 4 gavage (0.25 mL) 48 h after placement. Experimental treatment groups (groups 2 and 3) received bacteriophage and the control group (group 1) received sterile TSB 48 h following SE challenge. Group 2 was orally gavaged with 2.5×10 pfu (0.25 mL) of the final 9 bacteriophage mixture (passaged through chicks a s above). Group 3 was first orally gavaged 30 min prior to bacteriophage treatment with 0.25 mL of 5mM Mg (OH) 2 7 in an attempt to buffer the acidity of the proventriculus. Then group 3 also received 2.5×10 pfu bacteriophages 9 in the presence of 1mM Mg (OH) (0.25 mL). 2 Ten poults were randomly selected and humanely killed by CO inhalation from each group 6 h, 12 h, 24 h, or 48 2 h post-bacteriophage treatment. At each time point, 0.2 g of cecal contents were aseptically collected and diluted in 1.8 mL of sterile saline in a sterile glass tube. Two serial ten-fold dilutions of each sample were made and 100µL of the three concentrations of cecal contents was spread plated on brilliant green agar plates containing 8 novobiocin and nalidixic acid . The plates were 9 10 incubated for 18 h at 37°C and the number of colony determined for each sample. In Experiment 2, thirty day-of-hatch turkey poults were obtained and randomly divided into three groups of ten poults each. All poults were placed in brooder rings on litter, provided feed and water ad libitum and maintained at an age-appropriate temperature for the duration of the experiment. All poults received a challenge of termination of the experiment. At 24 h post-treatment, all poults were killed and 0.2 g of cecal contents were aseptically collected and diluted in 1.8 mL of saline. Two serial ten-fold dilutions were made and 100 µL of all three concentrations were spread plated on brilliant green agar plates containing novobiocin and nalidixic acid. The plates were incubated for 24 h at 37°C, SE colonies were counted and the number of cfu of SE per gram of cecal contents were calculated.
Statistical analysis: All data were analyzed within time points using a one-way analysis of variance . N o 12 means were found to be statistically significant.
Results
In experiment 1, poults were challenged with SE and then treated with bacteriophages alone or i n combination with Mg (OH) . At 6, 12 or 24 h post-2 treatment, SE recovery was numerically less i n bacteriophage-treated birds when compared to nontreated controls (Table 1) . However, these differences were not statistically significant at any of the time points evaluated. Additionally, by 48 h post treatment the cfu's of SE in the control group had declined from 21,329 cfu of SE to 5,189 cfu of SE and the group that received Mg (OH) in combination with bacteriophages had increased 2 from 4,064 cfu to 227,527 cfu at 48 h. In the group receiving bacteriophages in the absence of Mg ( OH) , no numerical difference in SE was 2 demonstrated at any time point evaluated. From this group we also recovered SE in numbers exceeding the untreated control at 48 h post-treatment. Although the bacteriophages administered were selected for the ability to survive the gastrointestinal tract, there was no suggestion of efficacy noted in the absence of Mg (OH) 2 (Table 1) . Poults were humanely killed by CO inhalation for SE recovery at selected times post-treatment, Poults were either untreated (control) 1 2 2 or treated with 2.5×10 pfu bacteriophages 48 h after SE challenge, 0.25 mL of 5mM Mg (OH) solution was administered 30 min before 9 3 2 bacteriophage suspension, which also contained 1mM Mg(OH) 2 (Table 2) . Similarly, repeated administration of Mg (OH) and bacteriophage treatment 2 every 6 h for 24 h did not reduce the recoverable SE as compared to the control.
Discussion
In these experiments we found that the selected bacteriophages were ineffective with co-administration of Mg (OH) at reducing SE in poults. Recently Koo et al. adsorption of the bacteriophage to the host cell (Eisenstark, 1967) . This interaction in the avian gastrointestinal tract could enhance the ability of the bacteriophages to adhere to host cells and thus proliferate.
We also observed in Experiment 1 increased S E recovery at 48 h in the treatment groups. This could be due to mutations in the SE that rendered it resistant to the bacteriophages administered. Although the numbers of SE in this treatment group dropped dramatically compared to controls, the bacteriophage treatment did not eliminate SE. Further, due to the populations of bacteriophage administered as treatments and their subsequent amplification in susceptible host SE, it is highly unlikely that the SE remaining in the ceca of treated poults did not encounter bacteriophages. Data from our laboratory indicates that resistant host bacteria occur in most in vitro cultures containing bacteriophages (unpublished data). This phenomena has also been reported by other investigators (Smith and Huggins, 1983) . However, we did not evaluate the recovered SE to determine if it was still susceptible to the bacteriophages utilized as treatment in this study. An alternative explanation for the observation of increased SE in the treated groups is lack of host specificity. Recently our laboratory has observed that our original wild-type bacteriophage library is not stringently host specific (unpublished data). Some of the bacteriophage isolates PHL 1-71 have demonstrated the ability to lyse non-pathogenic bacteria found as natural microflora of the cecae. This observation led us to consider the possibility that the pool of bacteriophages can potentially destroy normal microflora in addition to SE, giving bacteriophage-resistant SE the advantage of less competition. Although it is speculation, this could allow resistant SE to proliferate to high numbers a s demonstrated at 48 h in the treatment groups. In Experiment 2, re-administration of the bacteriophages did not prove efficacious. Repeated handling of the FoodNet, 2005. Preliminary FoodNet Data on the poults every 6 h could have contributed to stress and possibly immunosuppression in that group. In fact, the group that received repeated administration o f bacteriophages showed qualitative behavioral changes, including increased cannibalism which was not observed in the other two groups. Little research on bacteriophage treatment of poultry diseases has focused on oral administration o f bacteriophages. Bechieri et al. (1991) showed efficacy with oral administration of bacteriophages specific for Salmonella typhimurium, however the bacteriophages were only effective if administered simultaneously with the challenge. Recently Huff et al. (2002 Huff et al. ( , 2003 Huff et al. ( and 2005 showed remarkable efficacy at treating airsacculitis caused by E. coli with bacteriophages administered intramuscularly. When the same bacteriophages were administered orally in the drinking water, they were not effective. Possibly, oral administration of effective bacteriophages is difficult because of the harsh conditions encountered within the gastrointestinal tract. Enzymes and variable pH conditions are likely detrimental to the structure of the bacteriophages. Further research is needed to increase the efficacy of bacteriophage therapy for treating Salmonella infections.
